Your email has been successfully added to our mailing list.

×
-0.00179165600204761 -0.00179165600204761 0.000767852572306146 -0.000511901714870643 0.00383926286153055 0.00230355771691844 0.00588686972101367 -0.00819042743793192
Stock impact report

Pfizer profit down 12% as sales of off-patent drugs fall [Reuters]

Pfizer, Inc. (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
Company Research Source: Reuters
Pfizer profit down 12% as sales of off-patent drugs fall (Reuters) - Pfizer Inc reported a 12.4% drop in first-quarter profit on Tuesday, partly hurt by a drop in sales its off-patent pain treatment Lyrica. Net income attributable to shareholders fell to $3.40 billion, or 61 cents per share, in the quarter, from $3.88 billion, or 68 cents per share, a year earlier. Revenue at the company, which is set to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV, fell 8.3% to $12.03 billion. Show less Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PFE alerts
Opt-in for
PFE alerts

from News Quantified
Opt-in for
PFE alerts

from News Quantified